Jim Cramer names 6 e-commerce plays that are buys, says to wait on Amazon

Jim Cramer names 6 e-commerce plays that are buys, says to wait on Amazon


Cramer says the pain in e-commerce stocks is temporary

CNBC’s Jim Cramer on Friday offered investors a list of e-commerce plays he believes are worth buying, despite the group’s rough performance in 2022.

“There are still some e-commerce plays that I’m willing to get behind here, the ones that have truly prioritized profitability,” he said.

related investing news

Cowen downgrades Salesforce as company adjusts to a slower growth era

CNBC Pro

Here is his list: 

  1. Etsy
  2. Shopify
  3. Pinterest
  4. MercadoLibre
  5. Chewy
  6. Prologis

E-commerce stocks skyrocketed during the height of the Covid pandemic, as at-home consumers made purchases online rather than in-store. But when the economy reopened, consumers prioritized spending on travel and experiences over goods.

That shift, along with the Federal Reserve’s interest rate hikes, sent e-commerce stocks tumbling from their highs last year.

Cramer cautioned that while he believes the group’s struggles are temporary, it’s still too early to buy many of the names in the e-commerce space — including Amazon

He said that one of his biggest concerns with the company is that it needs to cut more costs. Amazon said earlier this month that it plans to lay off over 18,000 employees. 

While that might seem like a sizable cut, “this is a company with well over a million employees — to them, this is a drop in the bucket,” Cramer said.

But Amazon’s stock will eventually bottom, he said. “I think the business can eventually make a big comeback and there will come a point where the stock’s a screaming buy.”

Disclaimer: Cramer’s Charitable Trust owns shares of Amazon.

Jim Cramer gives his take on e-commerce stocks

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Moderna says FDA refuses to review its application for experimental flu shot
Business

Moderna says FDA refuses to review its application for experimental flu shot

A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration has refused to start a review of Moderna‘s application for its experimental flu shot, the company announced Tuesday, in another sign of the […]

Read More
Estee Lauder sues Walmart alleging ‘despicable’ sale of counterfeit beauty products
Business

Estee Lauder sues Walmart alleging ‘despicable’ sale of counterfeit beauty products

Walmart Inc. signage during the company’s listing at the Nasdaq MarketSite in New York, US, on Tuesday, Dec. 9, 2025. Michael Nagle | Bloomberg | Getty Images Estee Lauder sued Walmart in California federal court over allegations the big-box retailer sold counterfeit beauty products on its website and didn’t do enough to ensure only authorized […]

Read More
How this French building behemoth wants to solve the U.S. housing dilemma
Business

How this French building behemoth wants to solve the U.S. housing dilemma

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox. French […]

Read More